...
首页> 外文期刊>The Lancet >Cardiac death and reinfarction after 1 year in the Thrombus Aspiration during Percutaneous coronary intervention in Acute myocardial infarction Study (TAPAS): a 1-year follow-up study.
【24h】

Cardiac death and reinfarction after 1 year in the Thrombus Aspiration during Percutaneous coronary intervention in Acute myocardial infarction Study (TAPAS): a 1-year follow-up study.

机译:急性心肌梗死研究(TAPAS)中经皮冠状动脉介入治疗期间血栓抽吸1年后的心源性死亡和再梗塞:为期1年的随访研究。

获取原文
获取原文并翻译 | 示例

摘要

BACKGROUND: Percutaneous coronary intervention (PCI) for ST-elevation myocardial infarction can be complicated by spontaneous or angioplasty-induced embolisation of atherothrombotic material. Distal blockage induces microvascular obstruction and can result in less than optimum reperfusion of viable myocardium. The Thrombus Aspiration during Percutaneous coronary intervention in Acute myocardial infarction Study (TAPAS) found that thrombus aspiration resulted in improved myocardial reperfusion compared with conventional PCI, but whether this benefit improves clinical outcome is unknown. We aimed to investigate whether the early efficacy of thrombus aspiration seen in TAPAS translated into clinical benefit after 1 year. METHODS: Patients with ST-elevation myocardial infarction enrolled at the University Medical Centre Groningen were randomly assigned in a 1:1 ratio to either thrombus aspiration or conventional treatment, before undergoing initial coronary angiography. Exclusion criteria were rescue PCI after thrombolysis and known existence of a concomitant disease with life expectancy less than 6 months. Of the 1071 patients enrolled between January, 2005, and December, 2006, vital status at or beyond 1 year after randomisation was available for 1060 (99%). The primary endpoint was cardiac death or non-fatal reinfarction after 1 year, and analysis was by intention to treat. The TAPAS trial is registered with Current Controlled Trials number ISRCTN16716833. FINDINGS: Cardiac death at 1 year was 3.6% (19 of 535 patients) in the thrombus aspiration group and 6.7% (36 of 536) in the conventional PCI group (hazard ratio [HR] 1.93; 95% CI 1.11-3.37; p=0.020). 1-year cardiac death or non-fatal reinfarction occurred in 5.6% (30 of 535) of patients in the thrombus aspiration group and 9.9% (53 of 536) of patients in the conventional PCI group (HR 1.81; 95% CI 1.16-2.84; p=0.009). INTERPRETATION: Compared with conventional PCI, thrombus aspiration before stenting of the infarcted artery seems to improve the 1-year clinical outcome after PCI for ST-elevation myocardial infarction.
机译:背景:自发性或血管成形术诱发的动脉粥样硬化血栓形成材料栓塞可能会使ST抬高型心肌梗死的经皮冠状动脉介入治疗(PCI)复杂化。远端阻塞会引起微血管阻塞,并可能导致存活心肌的最佳再灌注不足。急性心肌梗死研究(TAPAS)中经皮冠状动脉介入治疗期间的血栓抽吸发现,与常规PCI相比,血栓抽吸可改善心肌的再灌注,但尚不清楚该益处是否能改善临床结果。我们旨在调查在TAPAS中观察到的血栓抽吸的早期疗效是否在1年后转化为临床获益。方法:在格罗宁根大学医学中心登记的ST段抬高型心肌梗死患者,在进行初次冠状动脉造影之前,以1:1比例随机分配血栓抽吸或常规治疗。排除标准为溶栓后的抢救性PCI和已知存在预期寿命少于6个月的伴随疾病。在2005年1月至2006年12月之间入组的1071名患者中,随机分组后1年或超过1年的生命状态可用1060(99%)。主要终点为1年后的心源性死亡或非致命性再梗塞,分析旨在进行治疗。 TAPAS试验已在国际对照试验编号ISRCTN16716833中注册。结论:常规PCI组在1年时的心脏死亡为3.6%(535名患者中的19名),常规PCI组为6.7%(536名中的36名)(危险比[HR] 1.93; 95%CI 1.11-3.37; p = 0.020)。常规PCI组(HR 1.81; 95%CI 1.16-)在血栓抽吸组的患者中发生5.6%(535例中的30%)的患者发生1年心源性死亡或非致命性再梗塞(HR 1.81; 95%CI 1.16) 2.84; p = 0.009)。解释:与常规PCI相比,在梗死动脉支架置入术前进行血栓抽吸似乎可以改善PCI后ST段抬高性心肌梗死的1年临床疗效。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号